Browse Items (1 total)

Pediatric patients between the ages of 12 months and 17 years with a confirmed malignancy who were scheduled to receive aprepitant as part of triple therapy antiemetic prophylaxis for a cycle of moderately- or highly emetogenic chemotherapy were…
Output Formats

atom, dcmes-xml, json, omeka-xml, rss2